{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:36:15Z","timestamp":1789994175733,"version":"4.0.1"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"suppl_3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,15]]},"DOI":"10.1093\/infdis\/jix179","type":"journal-article","created":{"date-parts":[[2017,4,11]],"date-time":"2017-04-11T03:09:58Z","timestamp":1491880198000},"page":"S431-S435","source":"Crossref","is-referenced-by-count":69,"title":["Antifungal Resistance: An Emerging Reality and A Global Challenge"],"prefix":"10.1093","volume":"216","author":[{"given":"Dimitrios P","family":"Kontoyiannis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,9,5]]},"reference":[{"key":"key\n\t\t\t\t20170906122420_CIT0001","volume-title":"The fungal kingdom\u2014diverse and essential roles in earth\u2019s ecosystem. A report based on a colloquium held November 2\u20134, 2007","year":"2008"},{"key":"key\n\t\t\t\t20170906122420_CIT0002","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/mmy\/myw060","article-title":"The anti-Aspergillus drug pipeline: is the glass half full or empty?","volume":"55","year":"2017","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20170906122420_CIT0003","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cid\/civ885","article-title":"Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles?","volume":"62","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170906122420_CIT0004","article-title":"Azole-resistant aspergillosis: epidemiology, molecular mechanisms and treatment","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170906122420_CIT0005","article-title":"The role of in vitro susceptibility testing in management of fungal infections","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170906122420_CIT0006","article-title":"MDR Candida: epidemiology, molecular mechanisms and treatment","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170906122420_CIT0007","article-title":"Culture-independent methods for the detection of resistance","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170906122420_CIT0008","article-title":"Animal models to assess drug resistance","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170906122420_CIT0009","article-title":"Novel Agents and Drug Targets to Meet the Challenges of Resistant Fungi","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170906122420_CIT0010","article-title":"Future research priorities in fungal resistance","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170906122420_CIT0011","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0140-6736(02)08162-X","article-title":"Antifungal drug resistance of pathogenic fungi","volume":"359","year":"2002","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170906122420_CIT0012","doi-asserted-by":"crossref","first-page":"11128","DOI":"10.1038\/ncomms11128","article-title":"Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance","volume":"7","year":"2016","journal-title":"Nat Commun"},{"key":"key\n\t\t\t\t20170906122420_CIT0013","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170906122420_CIT0014","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3201\/eid2201.151308","article-title":"Azole resistance of Aspergillus fumigatus in immunocompromised patients with invasive Aspergillosis","volume":"22","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170906122420_CIT0015","first-page":"1942","article-title":"Uncommon candida species fungemia among cancer patients, Houston, Texas, USA","volume":"21","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170906122420_CIT0016","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3201\/eid2106.140717","article-title":"Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus","volume":"21","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170906122420_CIT0017","first-page":"110","article-title":"Seagulls and beaches as reservoirs for multidrug-resistant Escherichia coli","volume":"16","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170906122420_CIT0018","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/CMR.00039-07","article-title":"Infections caused by Scedosporium spp","volume":"21","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20170906122420_CIT0019","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1128\/JCM.00917-07","article-title":"Molecular typing of Aspergillus terreus isolates collected in Houston, Texas, and Innsbruck, Austria: evidence of great genetic diversity","volume":"45","year":"2007","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170906122420_CIT0020","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00005792-199809000-00004","article-title":"Aspergillus nidulans infection in chronic granulomatous disease","volume":"77","year":"1998","journal-title":"Medicine (Baltimore)"},{"key":"key\n\t\t\t\t20170906122420_CIT0021","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/428780","article-title":"Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases","volume":"191","year":"2005","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170906122420_CIT0022","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1001\/archinte.160.17.2659","article-title":"Candida krusei fungemia. An escalating serious infection in immunocompromised patients","volume":"160","year":"2000","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20170906122420_CIT0023","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/myc.12081","article-title":"Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study","volume":"56","year":"2013","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20170906122420_CIT0024","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/QCO.0b013e3283321ce5","article-title":"Antifungal drug resistance: do molecular methods provide a way forward?","volume":"22","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"key\n\t\t\t\t20170906122420_CIT0025","first-page":"791","article-title":"MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis","volume":"6","year":"2015","journal-title":"Front Microbiol"},{"key":"key\n\t\t\t\t20170906122420_CIT0026","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/mmy\/myw080","article-title":"Performance evaluation of multiplex PCR including Aspergillus-not so simple!","volume":"55","year":"2017","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20170906122420_CIT0027","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/01.md.0000091182.93122.8e","article-title":"Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy","volume":"82","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"key\n\t\t\t\t20170906122420_CIT0028","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1592\/phco.2005.25.9.1174","article-title":"Aspergillus susceptibility testing in patients with cancer and invasive aspergillosis: difficulties in establishing correlation between in vitro susceptibility data and the outcome of initial amphotericin B therapy","volume":"25","year":"2005","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t20170906122420_CIT0029","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.riam.2016.04.001","article-title":"The role of epidemiological cutoff values (ECVs\/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds","volume":"33","year":"2016","journal-title":"Rev Iberoam Micol"},{"key":"key\n\t\t\t\t20170906122420_CIT0030","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1439-0507.1995.tb00065.x","article-title":"An evaluation of seven methods of testing in vitro susceptibility of clinical yeast isolates to fluconazole","volume":"38","year":"1995","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20170906122420_CIT0031","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1128\/AAC.05661-11","article-title":"The composition of the culture medium influences the \u03b2-1,3-glucan metabolism of Aspergillus fumigatus and the antifungal activity of inhibitors of \u03b2-1,3-glucan synthesis","volume":"56","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122420_CIT0032","first-page":"a019752","article-title":"Mechanisms of antifungal drug resistance","volume":"5","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"key\n\t\t\t\t20170906122420_CIT0033","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nature13575","article-title":"Antifungal drug resistance evoked via RNAi-dependent epimutations","volume":"513","year":"2014","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170906122420_CIT0034","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12275-016-5628-4","article-title":"The development of fluconazole resistance in Candida albicans\u2014an example of microevolution of a fungal pathogen","volume":"54","year":"2016","journal-title":"J Microbiol"},{"key":"key\n\t\t\t\t20170906122420_CIT0035","doi-asserted-by":"crossref","first-page":"e00662","DOI":"10.7554\/eLife.00662","article-title":"The evolution of drug resistance in clinical isolates of Candida albicans","volume":"4","year":"2015","journal-title":"Elife"},{"key":"key\n\t\t\t\t20170906122420_CIT0036","first-page":"1995","article-title":"Genetic drivers of multidrug resistance in Candida glabrata","volume":"7","year":"2016","journal-title":"Front Microbiol"},{"key":"key\n\t\t\t\t20170906122420_CIT0037","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drup.2015.10.001","article-title":"Defining the frontiers between antifungal resistance, tolerance and the concept of persistence","volume":"23","year":"2015","journal-title":"Drug Resist Updat"},{"key":"key\n\t\t\t\t20170906122420_CIT0038","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12281-014-0181-2","article-title":"Large-scale chromosomal changes and associated fitness consequences in pathogenic fungi","volume":"8","year":"2014","journal-title":"Curr Fungal Infect Rep"},{"key":"key\n\t\t\t\t20170906122420_CIT0039","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4161\/viru.3.1.18886","article-title":"Resistance to echinocandins comes at a cost: the impact of FKS1 hotspot mutations on Candida albicans fitness and virulence","volume":"3","year":"2012","journal-title":"Virulence"},{"key":"key\n\t\t\t\t20170906122420_CIT0040","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4161\/viru.20746","article-title":"The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida","volume":"3","year":"2012","journal-title":"Virulence"},{"key":"key\n\t\t\t\t20170906122420_CIT0041","article-title":"Changes in in vitro susceptibility patterns of Aspergillus to triazoles and correlation with aspergillosis outcome in a tertiary care cancer center (1999\u20132015)","journal-title":"Clin Infect Dis 2007; [Epub ahead of print]"},{"key":"key\n\t\t\t\t20170906122420_CIT0042","first-page":"e00536","article-title":"Genomic context of azole resistance mutations in Aspergillus fumigatus determined using whole-genome sequencing","volume":"6","year":"2015","journal-title":"MBio"},{"key":"key\n\t\t\t\t20170906122420_CIT0043","doi-asserted-by":"crossref","first-page":"6390","DOI":"10.1016\/j.bmc.2016.11.008","article-title":"Animal models in the pharmacokinetic\/pharmacodynamic evaluation of antimicrobial agents","volume":"24","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"key\n\t\t\t\t20170906122420_CIT0044","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1473-3099(06)70686-7","article-title":"Role of mini-host models in the study of medically important fungi","volume":"7","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20170906122420_CIT0045","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/cid\/civ1194","article-title":"Executive summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170906122420_CIT0046","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/cid\/ciw444","article-title":"Executive summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170906122420_CIT0047","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.2012.06795.x","article-title":"The impact of azole resistance on aspergillosis guidelines","volume":"1272","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"key\n\t\t\t\t20170906122420_CIT0048","first-page":"30","article-title":"International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus","volume":"21\u201322","year":"2015","journal-title":"Drug Resist Updat"},{"key":"key\n\t\t\t\t20170906122420_CIT0049","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nchembio.2007.24","article-title":"Targeting virulence: a new paradigm for antimicrobial therapy","volume":"3","year":"2007","journal-title":"Nat Chem Biol"},{"key":"key\n\t\t\t\t20170906122420_CIT0050","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1002\/eji.201344405","article-title":"The bacteriome-mycobiome interaction and antifungal host defense","volume":"44","year":"2014","journal-title":"Eur J Immunol"},{"key":"key\n\t\t\t\t20170906122420_CIT0051","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/QCO.0b013e32834e0680","article-title":"The case for antifungal stewardship","volume":"25","year":"2012","journal-title":"Curr Opin Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/216\/suppl_3\/S431\/19708768\/jix179.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T22:05:29Z","timestamp":1569017129000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jid\/article\/216\/suppl_3\/S431\/4107053\/Antifungal-Resistance-An-Emerging-Reality-and-A"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,15]]},"references-count":51,"journal-issue":{"issue":"suppl_3","published-online":{"date-parts":[[2017,9,5]]},"published-print":{"date-parts":[[2017,8,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jix179","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,15]]}}}